Frontiers in Pharmacology (Mar 2023)

Erratum: Wnt-pathway inhibitors with selective activity against triple-negative breast cancer: From thienopyrimidine to quinazoline inhibitors

  • Frontiers Production Office

DOI
https://doi.org/10.3389/fphar.2023.1173490
Journal volume & issue
Vol. 14

Abstract

Read online

No abstracts available.

Keywords